India’s Alembic Pharmaceuticals board OKs Rs. 3 billion of debentures

By Sarah Lizee

Olympia, Wash., June 12 – Alembic Pharmaceuticals Ltd. informed the Bombay Stock Exchange that its board of directors approved plans to issue up to Rs. 3 billion of redeemable nonconvertible debentures at a meeting on Wednesday.

The debentures will be issued via private placement in one or more tranches, according to a notice.

The Vadodara, India-based company manufactures pharmaceutical products, pharmaceutical substances and intermediates.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.